Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Raylis
- Development stage
- Phase 3
- Lead developer
- The Clinic of Men's Health and Couple Longevity
- Administration
- Oral
01
Overview
**Raylis** is an oral multi-herb phytotherapy product evaluated in a registered Phase 3 study for congestive pelvic-organ processes described as prostatostasis associated with reduced sexual activity in men. Each capsule was reported to contain ginseng root powder, false ginseng root powder, codonopsis root powder, Astragalus membranaceus root powder, and Epimedium alpinum herbal extract. It has no publicly established single molecular target or validated target-specific mechanism; its intended effects are based on the combined traditional phytotherapeutic use of its botanical constituents.
- Brand names
- Raylis
- Other names
- РайлисСирбида
Beyond the preview
Go deeper on Raylis.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Raylis.